DigestRedComo funciona
Red
/
Empresas
Sa
No verificado

Savara Inc.

Sobre qué escribimos

BiotecnologíaEventosFarmacéuticaMedicina - VariosSalud

66 Comunicados de prensa

Ver todos los comunicados de prensa
04/02/2026
Biotecnología
Farmacéutica
Salud
Eventos
Web y redes sociales
Savara Announces Participation in Upcoming Investor Healthcare Conferences
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
27/01/2026
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Mercado laboral
Industria
Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
16/01/2026
Biotecnología
VIH, SIDA y enfermedades autoinmunes
Salud
Farmacéutica
Medicina - Varios
Mercado de valores
Finanzas
Savara Announces New Employment Inducement Grant
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
08/01/2026
Salud
Sanidad
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Mercado laboral
Industria
PANTHERx® Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI*
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
22/12/2025
Ciencia
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Material médico sanitario
Medicina - Varios
Industria
Savara Resubmits the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
17/12/2025
Eventos
Web y redes sociales
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Savara Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
11/12/2025
Industria
Biotecnología
Material médico sanitario
Salud
Farmacéutica
Medicina - Varios
Savara Announces European Patent Office (EPO) Intends to Grant a Patent for the Liquid Formulation of MOLBREEVI*
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
02/12/2025
Biotecnología
Material médico sanitario
Salud
Farmacéutica
Medicina - Varios
Industria
Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
20/11/2025
Biotecnología
Farmacéutica
Salud
Eventos
Web y redes sociales
Savara Announces Participation in Upcoming Investor Healthcare Conferences
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
12/11/2025
Biotecnología
Sanidad
Farmacéutica
Salud
Mercado de valores
Savara Reports Third Quarter 2025 Financial Results and Provides Business Update
Fuente
Savara Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0